Clinigence Holdings (NUTX) Price & Analysis

Compare

339 Followers

NUTX Stock Chart & Stats

Day’s Range― - ―

52-Week Range$17.51 - $184.28

Previous CloseN/A

Volume3.28K

Average Volume (3M)225.35K

Market Cap

$449.52M

Enterprise Value$528.08M

Total Cash (Recent Filing)$84.73M

Total Debt (Recent Filing)$341.36M

Price to Earnings (P/E)6.9

Beta2.31

Next Earnings

Nov 06, 2025

EPS Estimate

1.03

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-5.43

Shares Outstanding5,555,116

10 Day Avg. Volume209,152

30 Day Avg. Volume225,350

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.17

Enterprise Value/Revenue0.85

Enterprise Value/Gross Profit1.73

Enterprise Value/Ebitda2.47

Forecast

1Y Price Target

$252.50

Price Target Upside194.01% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Expansion PlansNutex Health Inc. is on track to open 2–3 new micro-hospitals during 2025, indicating growth and expansion potential.

Revenue GrowthNutex reported a 1Q beat with revenue of $211.9M, up 214% year over year.

Successful ArbitrationSuccessful rate arbitration with payors accounted for approximately $105M of revenue, significantly higher than the estimate.

Bears Say

Accounting IssuesNutex filed an NT 10-Q notification of inability to timely file its 10-Q due to the incorrect accounting classification of certain non-cash obligations, leading to the need for restatements.

Legal ChallengesPotential headwinds to NUTX's stock price include accounting restatements, arbitration dynamics, and lawsuits against Nutex's primary arbitration vendor, HaloMD.

Clinigence Holdings News

Nutex Health price target lowered to $205 from $225 at Maxim

Maxim lowered the firm’s price target on Nutex Health (NUTX) to $205 from $225 and keeps a Buy...

10d ago

NUTX

Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness

In the opening hour of the evening session, U.S. equity futures are mixed: S&P 500 is flat, Nasdaq...

22d ago

NUE

UNH

Nutex Health reports Q2 revenue $244M, consensus $176.47M

Gross profit was $124.9M, or 51.2% of total revenue, for the three months ended June 30, 2025 as...

22d ago

NUTX

Nutex Health Appoints New Lead Independent Director

An update from Clinigence Holdings ( ($NUTX) ) is now available. On September 2, 2025, Nutex Health, Inc....

23h ago

NUTX

Nutex Health Faces Class Action Over Fraud Allegations

Nutex Health Inc. finds itself embroiled in a legal storm as a class action lawsuit accuses the company...

2d ago

NUTX

Clinigence Holdings Inc. Earnings Call: Growth Amid Challenges

Clinigence Holdings Inc (($NUTX)) has held its Q2 earnings call. Read on for the main highlights of the...

5d ago

NUTX

Nutex Health Faces Securities Class Action Lawsuit

Clinigence Holdings ( ($NUTX) ) just unveiled an update. On August 22, 2025, a securities class action complaint...

11d ago

NUTX

Clinigence Holdings Faces Nasdaq Delisting Notice

The latest announcement is out from Clinigence Holdings ( ($NUTX) ). On August 20, 2025, Nutex Health Inc....

15d ago

NUTX

Nutex Health Reports Strong Revenue Growth Amid Filing Delay

Clinigence Holdings Inc ( ($NUTX) ) has released its Q2 earnings. Here is a breakdown of the information...

21d ago

NUTX

Nutex Health Inc. Delays 10-Q Filing

Clinigence Holdings ( ($NUTX) ) has released a notification of late filing. Nutex Health Inc. has announced a...

22d ago

NUTX

Nutex Health ‘strongly disagrees’ with allegations in short report

Nutex Health (NUTX) provided the following response to a “misleading” short attack: “The Company is aware of the...

1M ago

NUTX

Blue Orca Capital short Nutex Health, says stock ‘un-investable’

In a recently published report, Blue Orca Capital said it is short Nutex Health (NUTX), “a reverse merger...

2M ago

NUTX

Nutex Health down 2% after Blue Orca publishes short report

Shares of Nutex Health (NUTX) are down $1.80, or 2%, to $109.40 in afternoon trading. Published first on...

2M ago

NUTX

Clinigence Holdings Stockholders Approve Key Decisions

An announcement from Clinigence Holdings ( ($NUTX) ) is now available. At the annual meeting of stockholders of...

2M ago

NUTX

NUTX FAQ

What was Clinigence Holdings’s price range in the past 12 months?

Clinigence Holdings lowest stock price was $17.51 and its highest was $184.28 in the past 12 months.

What is Clinigence Holdings’s market cap?

Clinigence Holdings’s market cap is $449.52M.

When is Clinigence Holdings’s upcoming earnings report date?

Clinigence Holdings’s upcoming earnings report date is Nov 06, 2025 which is in 62 days.

How were Clinigence Holdings’s earnings last quarter?

Clinigence Holdings released its earnings results on Aug 14, 2025. The company reported -$5.43 earnings per share for the quarter, missing the consensus estimate of -$1.477 by -$3.953.

Is Clinigence Holdings overvalued?

According to Wall Street analysts Clinigence Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Clinigence Holdings pay dividends?

Clinigence Holdings does not currently pay dividends.

What is Clinigence Holdings’s EPS estimate?

Clinigence Holdings’s EPS estimate is 1.03.

How many shares outstanding does Clinigence Holdings have?

Clinigence Holdings has 5,555,116 shares outstanding.

What happened to Clinigence Holdings’s price movement after its last earnings report?

Clinigence Holdings reported an EPS of -$5.43 in its last earnings report, missing expectations of -$1.477. Following the earnings report the stock price went down -16.395%.

Which hedge fund is a major shareholder of Clinigence Holdings?

Currently, no hedge funds are holding shares in NUTX

Clinigence Holdings Stock Smart Score

Outperform

Fundamentals

Return on Equity

51.65%

Trailing 12-Months

Asset Growth

88.46%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Clinigence Holdings

Clinigence Holdings (NUTX) is a healthcare technology company that specializes in providing data analytics and population health management solutions. The company operates in the healthcare sector, focusing on delivering innovative software and services that enhance the efficiency and effectiveness of healthcare providers. Clinigence's core offerings include advanced analytics platforms, telehealth solutions, and integrated care management tools, aimed at improving patient outcomes while reducing costs for healthcare organizations.

Clinigence Holdings (NUTX) Earnings & Revenues

Historic Earnings Reports

NUTX Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call highlights significant revenue growth, improved profitability, and strong patient satisfaction metrics. However, these positive factors are offset by concerns over delayed SEC filings, dependence on arbitration revenue, and potential litigation risks. Despite strong operational performance, the balance between highlights and lowlights suggests cautious optimism.View all NUTX earnings summaries

NUTX Stock 12 Month Forecast

Average Price Target

$252.50

▲(194.01% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","79":"$79","153":"$153","227":"$227","301":"$301"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$300.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":252.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$252.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":205,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$205.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,79,153,227,301],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.92,97.77230769230769,114.62461538461538,131.47692307692307,148.32923076923078,165.18153846153845,182.03384615384613,198.88615384615383,215.73846153846154,232.59076923076924,249.4430769230769,266.2953846153846,283.1476923076923,{"y":300,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.92,94.11846153846153,107.31692307692308,120.51538461538462,133.71384615384613,146.9123076923077,160.11076923076922,173.30923076923074,186.5076923076923,199.70615384615382,212.9046153846154,226.1030769230769,239.30153846153843,{"y":252.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,80.92,90.46461538461539,100.00923076923077,109.55384615384617,119.09846153846155,128.64307692307693,138.18769230769232,147.7323076923077,157.27692307692308,166.82153846153847,176.36615384615385,185.91076923076923,195.45538461538462,{"y":205,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.06,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.77,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.39,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.6,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.58,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.69,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.63,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.4,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":117.99,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":167.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.8,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.92,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >